Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
J Nat Prod ; 80(4): 1007-1014, 2017 04 28.
Artigo em Inglês | MEDLINE | ID: mdl-28282127

RESUMO

Three new monoterpene indole alkaloids (1-3) have been isolated from the bark of Geissospermum laeve, together with the known alkaloids (-)-leuconolam (4), geissolosimine (5), and geissospermine (6). The structures of 1-3 were elucidated by analysis of their HRMS and NMR spectroscopic data. The absolute configuration of geissolaevine (1) was deduced from the comparison of experimental and theoretically calculated ECD spectra. The isolation workflow was guided by a molecular networking-based dereplication strategy using an in-house database of monoterpene indole alkaloids. In addition, five known compounds previously undescribed in the Geissospermum genus were dereplicated from the G. laeve alkaloid extract network and were assigned with various levels of identification confidence. The antiparasitic activities against Plasmodium falciparum and Leishmania donovani as well as the cytotoxic activity against the MRC-5 cell line were determined for compounds 1-5.


Assuntos
Antimaláricos/isolamento & purificação , Antiparasitários/isolamento & purificação , Apocynaceae/química , Folhas de Planta/química , Alcaloides de Triptamina e Secologanina/isolamento & purificação , Antimaláricos/química , Antimaláricos/farmacologia , Antiparasitários/química , Antiparasitários/farmacologia , Ensaios de Seleção de Medicamentos Antitumorais , Guiana Francesa , Humanos , Alcaloides Indólicos/química , Leishmania donovani/efeitos dos fármacos , Estrutura Molecular , Ressonância Magnética Nuclear Biomolecular , Testes de Sensibilidade Parasitária , Plasmodium falciparum/efeitos dos fármacos , Alcaloides de Triptamina e Secologanina/química , Alcaloides de Triptamina e Secologanina/farmacologia
2.
Exp Neurol ; 253: 113-25, 2014 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-24389273

RESUMO

Both genetic and environmental factors likely contribute to the neuropathology of tauopathies, but it remains unclear how specific genetic backgrounds affect the susceptibility towards environmental toxins. Mutations in the tau gene have been associated with familial tauopathies, while annonacin, a plant-derived mitochondrial inhibitor, has been implicated in an environmental form of tauopathy. We therefore determined whether there was a pathogenic synergy between annonacin exposure and the expression of the R406W-tau mutation in transgenic mice. We found that annonacin exposure caused an increase in the number of neurons with phosphorylated tau in the somatodendritic compartment in several brain areas in R406W(+/+) mice as opposed to mice that had only the endogenous mouse tau (R406W(-/-)). Western blot analysis demonstrated a concomitant increase in total tau protein without increase in tau mRNA, but reduced proteasomal proteolytic activity in R406W(+/+), but not R406W(-/-) mice, upon annonacin-treatment. Phosphorylated tau levels exceeded the increase in total tau protein, along with increased levels of different tau kinases, foremost a striking increase in the p25/p35 ratio, known to activate the tau kinase Cdk5. In summary, we observed a synergistic interaction between annonacin exposure and the presence of the R406W-tau mutation, which resulted in reduced degradation, increased phosphorylation and redistribution of neuronal tau.


Assuntos
Encéfalo/efeitos dos fármacos , Inibidores Enzimáticos/farmacologia , Furanos/farmacologia , Regulação da Expressão Gênica/efeitos dos fármacos , Regulação da Expressão Gênica/genética , Lactonas/farmacologia , Proteínas tau/genética , Animais , Arginina/genética , Encéfalo/metabolismo , Relação Dose-Resposta a Droga , Humanos , Camundongos , Camundongos Endogâmicos C57BL , Camundongos Transgênicos , Microglia/efeitos dos fármacos , Proteínas Associadas aos Microtúbulos/metabolismo , Mitocôndrias/genética , Mitocôndrias/metabolismo , Mortalidade , Mutação/genética , Neurônios/efeitos dos fármacos , Fosforilação/efeitos dos fármacos , Fosforilação/genética , Triptofano/genética
3.
Mov Disord ; 20(12): 1629-33, 2005 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-16078200

RESUMO

Atypical parkinsonism in Guadeloupe has been associated with the consumption of fruit and infusions or decoctions prepared from leaves of Annona muricata L. (Annonaceae), which contains annonaceous acetogenins, lipophilic inhibitors of complex I of the mitochondrial respiratory chain. We have determined the concentrations of annonacin, the major acetogenin in A. muricata, in extracts of fruit and leaves by matrix-assisted laser desorption-ionization mass spectrometry. An average fruit is estimated to contain about 15 mg of annonacin, a can of commercial nectar 36 mg, and a cup of infusion or decoction 140 microg. As an indication of its potential toxicity, an adult who consumes one fruit or can of nectar a day is estimated to ingest over 1 year the amount of annonacin that induced brain lesions in rats receiving purified annonacin by intravenous infusion.


Assuntos
Annona/química , Álcoois Graxos/efeitos adversos , Álcoois Graxos/análise , Lactonas/efeitos adversos , Lactonas/análise , Transtornos Parkinsonianos/etiologia , Acetogeninas , Annona/toxicidade , Cromatografia Líquida de Alta Pressão/métodos , Álcoois Graxos/química , Guadalupe/epidemiologia , Humanos , Lactonas/química , Peso Molecular , Extratos Vegetais/efeitos adversos , Extratos Vegetais/análise , Extratos Vegetais/química , Espectrometria de Massas por Ionização e Dessorção a Laser Assistida por Matriz/métodos
4.
J Neurochem ; 88(1): 63-9, 2004 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-14675150

RESUMO

In Guadeloupe, epidemiological data have linked atypical parkinsonism with fruit and herbal teas from plants of the Annonaceae family, particularly Annona muricata. These plants contain a class of powerful, lipophilic complex I inhibitors, the annonaceous acetogenins. To determine the neurotoxic potential of these substances, we administered annonacin, the major acetogenin of A. muricata, to rats intravenously with Azlet osmotic minipumps (3.8 and 7.6 mg per kg per day for 28 days). Annonacin inhibited complex I in brain homogenates in a concentration-dependent manner, and, when administered systemically, entered the brain parenchyma, where it was detected by matrix-associated laser desorption ionization-time of flight mass spectrometry, and decreased brain ATP levels by 44%. In the absence of evident systemic toxicity, we observed neuropathological abnormalities in the basal ganglia and brainstem nuclei. Stereological cell counts showed significant loss of dopaminergic neurones in the substantia nigra (-31.7%), and cholinergic (-37.9%) and dopamine and cyclic AMP-regulated phosphoprotein (DARPP-32)-immunoreactive GABAergic neurones (-39.3%) in the striatum, accompanied by a significant increase in the number of astrocytes (35.4%) and microglial cells (73.4%). The distribution of the lesions was similar to that in patients with atypical parkinsonism. These data are compatible with the theory that annonaceous acetogenins, such as annonacin, might be implicated in the aetiology of Guadeloupean parkinsonism and support the hypothesis that some forms of parkinsonism might be induced by environmental toxins.


Assuntos
Corpo Estriado/efeitos dos fármacos , Complexo I de Transporte de Elétrons/antagonistas & inibidores , Furanos/toxicidade , Lactonas/toxicidade , Doenças Neurodegenerativas/induzido quimicamente , Extratos Vegetais/toxicidade , Substância Negra/efeitos dos fármacos , Trifosfato de Adenosina/metabolismo , Animais , Comportamento Animal/efeitos dos fármacos , Contagem de Células , Corpo Estriado/metabolismo , Corpo Estriado/patologia , Furanos/administração & dosagem , Gliose/induzido quimicamente , Gliose/patologia , Guadalupe , Infusões Intravenosas , Lactonas/administração & dosagem , Masculino , Mitocôndrias/enzimologia , Doenças Neurodegenerativas/enzimologia , Doenças Neurodegenerativas/patologia , Neurônios/efeitos dos fármacos , Neurônios/patologia , Transtornos Parkinsonianos/etiologia , Extratos Vegetais/administração & dosagem , Ratos , Ratos Endogâmicos Lew , Substância Negra/metabolismo , Substância Negra/patologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA